FIELD: medicine.
SUBSTANCE: method of studying thrombocyte aggregation is offered. Thrombocyte rich plasma is placed in a rheoscope chamber, mixed and measured for an integral optical density of all aggregates formed after cellular interaction, an integral optical density of each aggregate upon termination of an aggregation process, and the aggregate formation index R is calculated by formula: R=K/N×100 % where K is a number of large aggregates of the integral optical density more 151 standard units; N is total aggregates of the integral optical density more 10 standard units; 100 % is a coefficient specifying a percentage of the relation K/N.
EFFECT: method allows higher accuracy of studying the thrombocyte aggregation process and can be used for diagnosing a thrombosis risk.
2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THROMBOCYTE INTRAVASCULAR ACTIVATION ANALYSIS | 2009 |
|
RU2416796C1 |
| ANTITHROMBOTIC PREPARATION AND METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS | 2002 |
|
RU2205027C1 |
| HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
| DIAGNOSTIC TECHNIQUE FOR DISTURBED THROMBOCYTE AGGREGATION ACCOMPANYING MUCOVISCIDOSIS IN CHILDREN | 2013 |
|
RU2533287C1 |
| METHOD OF EARLY PREDICTION OF RISK OF DEVELOPING VASCULAR INVOLVEMENTS IN ONSET OF ENDOCRINOPATHIES | 2010 |
|
RU2426123C1 |
| METHOD OF ASSAY OF PRESENCE OR ABSENCE OF INHIBITORY ACTIVITY OF PLATELET AGGREGATION (PA1), PURIFIED AND ISOLATED INHIBITOR OF PLATELET ACTIVITY (PA1) AND/OR ITS TRUNCATED FORM, METHOD OF PURIFICATION OF PA1 FROM SNAKE VENOM, PHARMACEUTICAL COMPOSITION FOR PREVENTION OF THROMBUS FORMATION, METHOD OF INHIBITION OF THROMBUS FORMATION | 1990 |
|
RU2156468C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| THROMBOCYTE AGGREGATION-INHIBITING HETEROMERIC PEPTIDES BASED ON IMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2550223C1 |
| PLATELET-SPECIFIC CHIMERIC IMMUNOGLOBULIN AND METHODS OF ITS USING | 1994 |
|
RU2158135C2 |
